"Fluorobenzenes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of BENZENE that contain FLUORINE.
| Descriptor ID |
D005464
|
| MeSH Number(s) |
D02.455.426.559.389.358 D02.455.526.510.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluorobenzenes".
Below are MeSH descriptors whose meaning is more specific than "Fluorobenzenes".
This graph shows the total number of publications written about "Fluorobenzenes" by people in this website by year, and whether "Fluorobenzenes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluorobenzenes" by people in Profiles.
-
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PLoS One. 2014; 9(2):e89732.
-
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease. Expert Opin Pharmacother. 2011 Dec; 12(17):2599-604.
-
STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D. Cardiovasc Ther. 2011 Apr; 29(2):146-52.
-
Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation). Thromb Res. 2010 Nov; 126(5):e397-9.
-
Achieving treatment goals in low-risk, asymptomatic patients. J Am Osteopath Assoc. 2010 Apr; 110(4 Suppl 4):S7-13.
-
Rediscovering bile acid sequestrants. Diabetes Obes Metab. 2009 Dec; 11(12):1114-21.
-
Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis. J Cardiovasc Pharmacol. 2004 Oct; 44(4):446-52.